Sponsor Pipeline

Paolo Caimi, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06916767 Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory… Relapsed CLL Recruiting
NCT05053659 Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma Relapsed Non Hodgkin Lymphoma Active, Not Recruiting
NCT07225439 Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of… Non Hodgkin Lymphoma Not Yet Recruiting
Disease Areas
Non-Hodgkin Lymphoma (2) Chronic Lymphocytic Leukemia (CLL) (2) Leukemia (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when Paolo Caimi, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free